A Study of Lithium and Enlicitide in Healthy Adult Participants (MK-0616-034)

PHASE1CompletedINTERVENTIONAL

Enrollment

Participants

Timeline

Start Date

January 2, 2025

Primary Completion Date

January 27, 2025

Study Completion Date

February 6, 2025

Conditions

Healthy

Interventions

DRUG

lithium carbonate

Oral capsule

DRUG

enlicitide

Oral tablet

Trial Locations (1)

Celerion ( Site 0002), Tempe

All Listed Sponsors

lead

Merck Sharp & Dohme LLC

INDUSTRY

NCT06719544 - A Study of Lithium and Enlicitide in Healthy Adult Participants (MK-0616-034) | Biotech Hunter | Biotech Hunter